Related Experiment Video
Updated: Jan 11, 2026

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
Predicting Pulmonary Exacerbations in Cystic Fibrosis Using Inflammation-Based Scoring Systems
Raphael S Reitmeier1, Melanie Götschke1, Julia Walter1,2
1Department of Medicine V, LMU University Hospital, LMU Munich, 81377 Munich, Germany.
The CRP/albumin ratio effectively predicts pulmonary exacerbations (PEx) in people with cystic fibrosis (pwCF). This simple marker identifies individuals at higher risk, aiding clinical practice and PEx prevention strategies.
Area of Science:
- Pulmonology
- Clinical Medicine
- Biomarkers
Background:
- Pulmonary exacerbations (PEx) significantly impact outcomes for people with cystic fibrosis (pwCF).
- Predicting PEx is crucial for effective management and prevention strategies.
- Current definitions of PEx lack universal consensus, complicating risk assessment.
Purpose of the Study:
- To identify individuals with cystic fibrosis (pwCF) at risk for future pulmonary exacerbations (PEx).
- To evaluate established and novel markers of chronic inflammation for PEx prediction.
- To compare the efficacy of various inflammatory markers and scoring systems in predicting PEx.
Main Methods:
- Retrospective analysis of 131 adults with cystic fibrosis (CF) over a 3-year period.
- PEx defined as the need for intravenous antibiotic treatment.
- Comparison of inflammatory markers including CRP/albumin ratio, neutrophil-to-lymphocyte ratio (NLR), and lymphocyte-to-monocyte ratio (LMR), alongside Glasgow Prognostic Scores (GPS).
Main Results:
- 57.3% of pwCF experienced PEx during the follow-up period.
- Multivariate analysis identified CRP(log), CRP/albumin ratio, decreased LMR, increased NLR, and GPS as significant predictors of PEx.
- The CRP/albumin ratio demonstrated the highest predictive performance for PEx in pwCF.
Conclusions:
- Inflammation-based scoring systems can predict PEx in pwCF.
- The easily calculated CRP/albumin ratio reliably identifies pwCF at increased risk for PEx.
- The CRP/albumin ratio is a promising tool for clinical application in managing PEx risk.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

